Tags

Type your tag names separated by a space and hit enter

Henipavirus pathogenesis and antiviral approaches.
Expert Rev Anti Infect Ther. 2015 Mar; 13(3):343-54.ER

Abstract

Hendra virus and Nipah virus are closely related, recently emerged zoonotic paramyxoviruses, belonging to the Henipavirus genus. Both viruses induce generalized vasculitis affecting particularly the respiratory tract and CNS. The exceptionally broad species tropism of Henipavirus, the high case fatality rate and person-to-person transmission associated with Nipah virus outbreaks emphasize the necessity of effective antiviral strategies for these intriguing threatening pathogens. Current therapeutic approaches, validated in animal models, target early steps in viral infection; they include the use of neutralizing virus-specific antibodies and blocking membrane fusion with peptides that bind the viral fusion protein. A better understanding of Henipavirus pathogenesis is critical for the further advancement of antiviral treatment, and we summarize here the recent progress in the field.

Authors+Show Affiliations

CIRI, International Center for Infectiology Research, 21 Avenue Tony Garnier, 69365 Lyon Cedex 07, France.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

25634624

Citation

Mathieu, Cyrille, and Branka Horvat. "Henipavirus Pathogenesis and Antiviral Approaches." Expert Review of Anti-infective Therapy, vol. 13, no. 3, 2015, pp. 343-54.
Mathieu C, Horvat B. Henipavirus pathogenesis and antiviral approaches. Expert Rev Anti Infect Ther. 2015;13(3):343-54.
Mathieu, C., & Horvat, B. (2015). Henipavirus pathogenesis and antiviral approaches. Expert Review of Anti-infective Therapy, 13(3), 343-54. https://doi.org/10.1586/14787210.2015.1001838
Mathieu C, Horvat B. Henipavirus Pathogenesis and Antiviral Approaches. Expert Rev Anti Infect Ther. 2015;13(3):343-54. PubMed PMID: 25634624.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Henipavirus pathogenesis and antiviral approaches. AU - Mathieu,Cyrille, AU - Horvat,Branka, Y1 - 2015/01/29/ PY - 2015/1/31/entrez PY - 2015/1/31/pubmed PY - 2015/10/20/medline KW - Hendra virus KW - Nipah virus KW - bats KW - emergent diseases KW - encephalitis SP - 343 EP - 54 JF - Expert review of anti-infective therapy JO - Expert Rev Anti Infect Ther VL - 13 IS - 3 N2 - Hendra virus and Nipah virus are closely related, recently emerged zoonotic paramyxoviruses, belonging to the Henipavirus genus. Both viruses induce generalized vasculitis affecting particularly the respiratory tract and CNS. The exceptionally broad species tropism of Henipavirus, the high case fatality rate and person-to-person transmission associated with Nipah virus outbreaks emphasize the necessity of effective antiviral strategies for these intriguing threatening pathogens. Current therapeutic approaches, validated in animal models, target early steps in viral infection; they include the use of neutralizing virus-specific antibodies and blocking membrane fusion with peptides that bind the viral fusion protein. A better understanding of Henipavirus pathogenesis is critical for the further advancement of antiviral treatment, and we summarize here the recent progress in the field. SN - 1744-8336 UR - https://www.unboundmedicine.com/medline/citation/25634624/Henipavirus_pathogenesis_and_antiviral_approaches_ DB - PRIME DP - Unbound Medicine ER -